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Abstract
Epithelial-mesenchymal transition (EMT) is an important mechanism in carcinogenesis. To determine the mechanisms that
are involved in the regulation of EMT, it is crucial to develop new biomarkers and therapeutic targets towards cancers. In
this study, when TGFb1 and TNFa were used to induce EMT in human lung carcinoma A549 cells, we found an increase in an
epithelial cell tight junction marker, Claudin 1. We further identified that it was the TNFa and not the TGFb1 that induced
the fibroblast-like morphology changes. TNFa also caused the increase in Claudin-1 gene expression and protein levels in
Triton X-100 soluble cytoplasm fraction. Down-regulation of Claudin-1, using small interfering RNA (siRNA), inhibited 75% of
TNFa-induced gene expression changes. Claudin-1 siRNA effectively blocked TNFa-induced molecular functional networks
related to inflammation and cell movement. Claudin-1 siRNA was able to significantly reduce TNF-enhanced cell migration
and fibroblast-like morphology. Furthermore, over expression of Claudin 1 with a Claudin 1-pcDNA3.1/V5-His vector
enhanced cell migration. In conclusion, these observations indicate that Claudin 1 acts as a critical signal mediator in TNFa-
induced gene expression and cell migration in human lung cancer cells. Further analyses of these cellular processes may be
helpful in developing novel therapeutic strategies.
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Introduction
Inflammatory mediators are important constituents of local
environment for tumors, and evidences suggest that they are
closely linked to cancer and inflammation [1]. For instance, many
chronic inflammatory diseases are associated with greater risk of
cancer [2]. One of the key mediators implicated in inflammation-
associated cancer is tumor necrosis factor alpha (TNFa) [3].
Although TNFa was first identified for its ability to induce rapid
hemorrhagic necrosis of experimental cancers, TNFa is now
known to be produced in cancer cells as an endogenous tumor
promoter [2,3]. Animal model studies demonstrate that TNFa has
pro-cancer actions [4,5]. TNFa2/2 and TNFR12/2 mice are
resistant to chemically induced carcinogenesis in the skin [6].
TNFR12/2 mice are resistant to chemical carcinogenesis in the
liver [7], and in the development of liver metastasis in
experimental colon cancer [8]. Furthermore, TNFa is frequently
detected in human cancers with poor prognosis, such as ovarian,
renal and breast cancers [9]. TNFa has been suggested as a target
for renal-cell carcinoma treatment [10].
TNFa is involved in epithelial-mesenchymal transition (EMT)
[11]. It enhances transforming-growth factor b1 (TGFb1)-induced
EMT in multiple cancer cell types [12,13]. TNFa induces the
malignant progression of epithelial tumors by controlling cell
migration, invasion and metastasis. During the progression of
EMT, tight junction (TJ) proteins, such as Claudins and
Occludins, and adherens junction proteins, such as E-Cadherin,
are usually down-regulated [12–17]. TNFa also induces internal-
ization of TJ proteins [18], decreases trans-epithelial electrical
resistance, and increases the paracellular permeability of ions and
normally impermeable molecules [19].
The Claudin family of proteins consists of 24 members and
plays an integral role in the formation and function of tight
junctions [20,21]. Claudin family members interact with each
other through homo- and heterophilic interactions [21,22]. As TJ
proteins, Claudins are crucial for the maintenance of cellular
polarity and paracellular transportation of molecules. Claudin
proteins can be up-regulated and mis-localized in cancer cells [21].
The expression of Claudin 1 increases during tumorigenesis of
colon cancer [23], melanoma [24], oral squamous cell carcinoma
[25] and hepatocellular carcinoma [26].
In the present study, human lung carcinoma A549 cells were
treated with TNFa and TGFb1 to induce EMT. The expression of
Claudin 1 was increased in response to TNFa challenge. Further
studies indicated that Claudin 1 plays a crucial role in TNFa-
induced gene expression and cell migration in human lung
carcinoma cells.
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Cell line, antibodies and other reagents
Human lung adenocarcinoma A549 cells and MDCK cells were
grown in DMEM medium supplied with 10% fetal bovine serum,
1% penicillin-streptomycin, and 1% glutamine. Cells were
cultured in a standard humidified incubator at 37uC with 5%
CO2.
Antibodies for ZO-1, E-Cadherin, Occludin and Claudin-1
were from Zymed Laboratories (S. San Francisco, CA). Antibody
for Vimentin was from Cell Signaling Technology (Beverly, MA).
Antibody for GAPDH was from Santa Cruz Biotechnology (Santa
Cruz, CA). Horseradish peroxidase (HRP)-conjugated goat anti-
mouse and anti-rabbit secondary antibodies were from Amersham
Pharmacia Biotech (Piscataway, NJ). Alexa Fluor 488 labeled goat
anti-mouse and anti-rabbit secondary antibodies, rhodamine
phalloidin, and Hoechst dye 33342 were from Invitrogen
(Carlsbad, CA). Human TNFa was from R&D Systems Inc.
(Minneapolis, MN). Human TGFb1 was from Austral Biological
(San Ramon, CA).
Immunofluorescent staining and microscopy
Cells were stained as previously described [27–29]. A549 cells
were cultured on glass coverslips (VWR, Mississauga, Canada).
After different treatments, cells were fixed with 4% paraformal-
dehyde, permeabilized with 0.1% Triton X-100, blocked with 1%
BSA, stained with designated antibodies, rhodamine phalloidin
and Hoechst dye 33342. After gentle washing, coverslips were
mounted on glass slides with Dako fluorescence mounting medium
(Dako, Mississauga, Canada). Slides were examined as previously
described [27–29]. Isotype-matched mouse or rabbit IgG were
used as negative control with the same dilutions as the primary
antibodies.
Figure 1. TNFa and TGFb1 induce EMT in A549 cells. (A) The combined treatment of TNFa (20 ng/ml) and TGFb1 (10 ng/ml) for 72 h induced
morphological alterations characterized as fibroblast-like cells. (B) TNFa and TGFb1 treatment reduced expression of E-Cadherin at cell-to-cell
contacts, and increased formation of F-actin stress fibers. Cells were immunostained with an anti-E-Cadherin antibody and counterstained F-actin and
nuclei with rhodamine phalloidin and Hoechst 33342, respectively. (C) The redistribution of E-cadherin after TGFb and TNFa treatment from the cell-
to-cell contacts to cytosol was further demonstrated with confocal microscopy at higher maginification. (D) The 72 h treatment with TNFa and TGFb1
decreased expressions of E-Cadherin and Occludin, epithelial markers, and increased expressions of Vimentin, a mesenchymal marker, in A549 cells.
Surprisingly, the expression of Claudin 1, an epithelial marker, was increased as analyzed by western blotting.
doi:10.1371/journal.pone.0038049.g001
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Immunoblotting experiments were performed according to
procedures described previously [30–33]. Triton X-100 soluble
and insoluble protein fractions were prepared as described by
Nishiyama and coworkers [34]. Briefly, cells were lysed with
modified radioimmune precipitation assay buffer containing 1%
Triton X-100. Cell lysate was centrifuged (12,000 rpm for 10 min
at 4uC), and the supernatant was collected as the Trinton X-
soluble fraction. The remaining pellet was resuspended in 60 mlo f
lysis buffer containing 1% SDS. The resulting suspension was
centrifuged (12,000 rpm for 10 min at 4uC) and the supernatant
was collected as the Triton-X insoluble fraction.
Real-time quantitative RT-PCR
The qRT-PCR primers used for human Claudin-1 were 59-
GCGCGATATTTCTTCTTGCAGG-39 (Forward) and 59-
TTCGTACCTGGCATTGACTGG-39 (Reverse) [35]. The
primers used for human succinate dehydrogenase complex subunit
A (SDHA) were 59-CGGCATTCCCACCAACTAC-39 (Forward)
and 59-GGCCGGGCACAATCTG-39 (Reverse) [36]. Primers for
other genes are available upon request. Total RNA was extracted
from A549 cells with TRIZOL Reagent (Invitrogen). qRT-PCR
was performed using 26QuantiTect SYBR Green PCR kit
(Qiagen, Mississauga, Canada) on LightCycler480 (Roche,
Mannheim, Germany) as described [37,38]. Each assay included
a standard curve of five serial dilutions and a no-template negative
control. The gene expression levels were normalized to the level of
SDHA as a house-keeping gene.
siRNA transfection
Claudin 1 siRNA was purchased from Santa Cruz Biotechnol-
ogy. Cells were transfected with 50 nM Claudin 1 siRNAs using
the oligofectamine reagent (Invitrogen) [31–33,36,39]. The
medium containing siRNA was replaced with a fresh medium
with or without TNFa 24 h after transfection. The siSTABLE V2
non-targeting siRNA#1 from Dharmacon (Lafayette, CO) was
Figure 2. TNFa alone induces fibroblast-like morphology and Claudin 1 expression. (A) TNFa alone induced fibroblast-like morphological
alteration, reduced cell-to-cell contacts, and increased F-actin stress fibers. A549 cells treated with TNFa, TGFb1 or TNFa and TGFb1 together for 72 h
were examined with light microscopy and stained with rhodamine phalloidin to visualize F-actin structures. TNFa-induced changes were similar as
that of the TNFa and TGFb1 treatment, whereas TGFb1 alone did not induce these changes. (B) Protein levels of E-Cadherin were more effectively
reduced by TGFb1 than TNFa. TNFa alone increased Claudin 1 expression, whereas TGFb1 had little effects on Claudin 1 after 24 h or 48 h treatment,
and even increased it after 72 h treatment, as determined by western blotting. (C) In MDCK cells, TGFb1 reduced Claudin 1 after 24, 48 or 72 h
treatment. (D) Expression levels of Claudin 1 mRNA were significantly increased by TNFa in a time-dependent manner as measured by real-time
quantitative RT-PCR. Mean 6 SEM. n=3 experiments. *p,0.05 (compared with control at 24 h). #p,0.05 (compared with control at 48 h).
doi:10.1371/journal.pone.0038049.g002
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transfected cells were harvested at different days after transfection.
Microarray and data analysis
For microarray study, four groups were prepared (i.e., cells
treated with or without TNFa and in the presence of Claudin 1
siRNA or control siRNA) and were tested with three biological
replicates for each group. Total RNA was extracted using RNeasy
kit (Qiagen, Valencia, CA), and cDNA was synthesized with High-
Capacity cDNA Reverse Transcription kits (Applied Biosystems,
Foster City, CA) on a PTC-100
TM Programmable Thermal
controller (MJ Research Inc., Watertown, MA). The RNA
Integrity Number (RIN) was determined by Agilent Bioanalyzer
2100 (Agilent Technologies, Inc., Santa Clara, CA). Human Gene
ST 1.0 chips (28,132 spotted genes) from Affymetrix (Santa Clara,
CA) were used. Affymetrix CEL files were imported into Partek
software (Partek Inc., St. Louis, MO) using the default Partek
normalization parameters. Probe-level data were pre-processed
with robust multi-array average (RMA) analyses, which include
background correction, normalization, and summarization. Data
normalization was performed across all arrays, using quartile
normalization. The processed values were then compiled, or
summarized, using the median polish technique, to generate a
single measure of expression. Principle Component Analysis (PCA)
was performed using Partek. Hierarchical cluster analysis was
performed with significantly changed genes (p,0.001) using two-
way ANOVA. Differential expression analysis was performed
using Significance Analysis of Microarray (SAM) [40]. Signal
transduction network was analyzed with Ingenuity Pathway
Analysis (IPA)(Ingenuity Systems, Inc., Redwood City, CA) [36].
The original microarray data have been deposited to GEO
Repository (accession number GSE 32254).
Wound-healing assay
Wounds were created in confluent cells using a pipette tip [28].
The cells were then rinsed with medium to remove floating cells
and debris. TNFa and/or TGFb1 containing medium was added.
To test the effects of serum and/or EGF on cell migration, after
siRNA transfection confluent cells were serum starved before
wounding. Cells were then treated with 10% FBS, and/or 50 ng/
ml EGF [41]. The culture plates were incubated at 37uC. Wounds
were measured at 0, 6, 12 and 18 h. Assays were repeated four
times for each condition.
Cell proliferation assay
The proliferation assays were performed to determine the effect
of TNFa and/or TGFb1 on the cell growth over time as described
previously [42]. In brief, A549 cells were seeded into 96-well cell
culture plates at a density of 5610
3 cells/well and incubated for
48 h prior to the treatments. The medium was replaced with
100 ml fresh one containing 20 ng/ml TNFa and/or 10 ng/ml
TGFb1. The assay was performed at 0, 8, 18 and 24 h after the
treatments in quadruplicates with CellTiter 96
R AQueous One
Solution Cell Proliferation Assay (Promega, Madison, WI). At
Figure 3. TNFa-induced Claudin 1 protein is mainly in the cytosolic fraction. (A) At 24, 48 h after treating the cells with TNFa, expression of
Claudin 1 protein was increased mainly in cytoplasm. A549 cells were immunostained with an anti-Claudin 1 antibody and counterstained F-actin and
nuclei with rhodamine phalloidin and Hoechst 33342, respectively. (B) Confocal microscopy further confirmed the cytosolic distribution of Claudin1
in both control and TNFa groups. (C) Claudin 1 and GAPDH were mainly found in the Triton X-100 soluble (S) cytoplasm fraction, whereas ZO-1 and
Occludin were mainly in the Triton X-100 insoluble cytoskeletal pellets (P). A549 cells treated with or without TNFa (20 ng/ml for 24 h) were lyzed and
separated into Triton X-100 soluble and insoluble fractions for immunoblotting.
doi:10.1371/journal.pone.0038049.g003
Claudin 1 in TNFa Signaling and Cell Migration
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e38049each time point, 20 ml of the assay solution was added to each well
and incubated for 1 h at 37uC. The plate was then read on a 96
well plate reader (ThermoLab system, Opsys MR) at 490 nm. The
absorbance values were plotted as a function of time for each
treatment to show the cell proliferation profile.
Gelatin zymography
The cell-conditioned media were diluted with sample buffer
(5% SDS, 20% glycerol in 0.5 M Tris, pH 6.8, containing 0.02%
bromophenol blue), and loaded in a 10% zymogram gel
containing 0.1% gelatin (Sigma-Aldrich, St. Louis, MO) [27].
After electrophoresis, the gels were washed for 30 min in 2.5%
Triton X-100 and incubated overnight at 37uC in 50 mM Tris,
pH 7.4, 5 mM CaCl2, 0.02% Brij 35. The gels were stained with
0.5% Coomassie Blue R-250 in 50% methanol and 10% acetic
acid overnight at room temperature on a rotary shaker. The gels
were de-stained for 5 h in 50% methanol and 10% acetic acid.
The areas where the staining was digested were identified.
Claudin 1-pcDNA transfection
Claudin 1-pcDNA3.1/V5-His plasmid was given by Dr.
Patricia Pintor dos Reis and Dr. Suzanne Kamel-Reid (University
of Toronto), and an empty-pcDNA3.1/V5-His plasmid was used
as a negative control [25]. Cells were seeded in a 6-well plate at
5.0610
5 cells/well and incubated overnight at 37uC. Cells were
transfected with 500 ng/well Claudin 1-pcDNA or empty-pcDNA
plasmids using Lipofectamine
TM 2000 reagent (Invitrogen). The
media containing plasmids were replaced with fresh medium with
or without TNFa at 24 h after transfection. For protein studies,
the siRNA transfected cells were harvested at 48 h after
transfection.
Statistical analysis
Statistical analyses were carried out using Tukey-Kramer HSD
test. Differences are considered significant when the P value was
less than 0.05. Statistical analyses were performed using JMP
version 5 (SAS Institute Inc., Cary, NC).
Figure 4. Down-regulation of Claudin 1 with siRNA significantly blocked TNFa-induced gene expression. (A) Claudin 1 siRNA effectively
reduced both basal and TNFa-induced gene expression of Claudin 1 (reading from microarray). (B) Principle Component Analysis (PCA) showed that
the overall gene expression profiles are separated based on the Claudin 1 siRNA transfection and TNFa treatment. (C) Hierarchical clustering analysis
demonstrates that gene expression patterns are highly dependent upon Claudin 1 siRNA transfection and TNFa treatments. A two-way ANOVA
showed that 2,490 genes were significantly different. Red: up-regulated; blue: down-regulated. (D) Claudin 1 siRNA blocked 75% of the TNFa-induced
gene expression changes. The gene expressions that were significantly changed by TNFa were defined with FDR q value less than 5.0% and fold of
change greater than 1.3 by SAM analysis. Venn diagram shows that 75% of TNFa-induced expression changes were not shown in Claudin 1 siRNA
transfected cells.
doi:10.1371/journal.pone.0038049.g004
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Induction of EMT by TGFb1 and TNFa in human lung
carcinoma A549 cells
To investigate EMT in human lung carcinoma A549 cells, we
treated cells with TNFa (20 ng/ml) and TGFb1 (10 ng/ml) for
72 h. The combined treatment of TNFa and TGFb1 induced
morphological changes characterized as fibroblast-like cells
(Figure 1A). Immunofluorescent staining demonstrated that the
combined treatment with TNFa and TGFb1 reduced expression
of E-Cadherin, and re-distributed E-Cadherin from surface
membrane to more diffuse in the cytoplasm (Figure 1B left panel).
These changes were confirmed with confocal microscopy at higher
magnification (Figure 1C). The F-actin staining showed strong
cortical staining in the control cells, whereas more stress fibers can
be seen in elongated fibroblast-like cells after TGFb1 and TNFa
treatment (Figure 1B, middle panel). Western blotting revealed
that TNFa and TGFb1 together decreased expressions of E-
Cadherin and Occludin, typical epithelial adherens and TJ marker
proteins, and increased expressions of Vimentin, a typical
mesenchymal marker (Figure 1D). Claudin 1, one of the epithelial
TJ markers, however, was increased after TGFb1 and TNFa
treatment (Figure 1D).
TNFa induces morphologic alteration and Claudin 1
expression in A549 cells
To investigate the main signal that induces the morphologic
alternation, we treated A549 cells with TNFa and/or TGFb1 for
72 h. The changes in cell morphology and F-actin structures were
determined with phase contrast microscopy and F-actin staining.
TNFa alone induced the fibroblast-like morphological change of
the cells with formation of F-actin stress fibers, and reduced cell-to-
cell contact. On the other hand, TGFb1 alone did not induce
these changes (Figure 2A).
To investigate whether the change in the morphology of the
cells are associated with changes of EMT markers, we treated cells
with TNFa, TGFb1, or the both. In untreated cells, the protein
levels of E-Cadherin continued to increase from 24 h to 72 h. In
TGFb1 treated cells, E-Cadherin levels were inhibited; the band
was seen only at the 72 h. In TNFa treated cells, E-Cadherin
protein was found at 48 h and 72 h groups at lower levels than
untreated controls. The inhibitory effect was enhanced by the
combined TNFa and TGFb1 treatment (Figure 2B). Claudin 1
expression was increased by TNFa alone. TGFb1 alone slightly
reduced Claudin 1 at 24 h and 48 h. The effects of the combined
use of TNFa and TGFb1 on Claudin 1 levels were very similar to
the effect of TNFa alone (Figure 2B). In MDCK cells, TGFb1
decreased Claudin 1 expression in a time dependent fashion [15].
When we stimulated MDCK cells with TGFb1 (10 ng/ml),
decreased Claudin 1 was also found (Figure 2C), suggesting the less
inhibitory of TGFb1 to Claudin 1 in A549 cells could be cell type
specific. The basal expression level of Claudin 1 mRNA was
increased in a time-dependent manner between 24 and 48 h,
which was significantly enhanced by TNFa stimulation as
determined by real-time quantitative RT-PCR (Figure 2D).
Furthermore, immunofluorescent staining demonstrated that
TNFa-induced Claudin 1 protein expression was mainly found in
the cytoplasm and not at the boundary of cell-to-cell contacts
(Figure 3A). The cytosolic distribution of Claudin 1 was further
demonstrated with confocal microscopy at higher magnification
(Figure 3B). Assembly of tight junctions recruits tight junction
proteins into complexes; therefore, make them resistant to
detergent-salt extractions. Conversely, disassembly of tight junc-
tion may result in internalization or diffuse cytoplasmic distribu-
Figure 5. Validation of gene expression by real-time quantita-
tive RT-PCR. The expression of six genes (BAAT, TM4SF4, CCL5,
TNFAIP3, IL-6, and IL-8) in Claudin 1 siRNA transfected cells were
compared with control siRNA transfected cells treated with or without
TNFa. The microarray results are plotted in the left column. The qRT-
PCR results normalized to the level of SDHA are plotted in the right
column. N=4, Mean 6 SEM.
doi:10.1371/journal.pone.0038049.g005
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detergent salt solutions [34]. Thus, to further determine the
distribution of Claudin 1, we used Triton-X100 extraction
followed by western blotting. Claudin 1 was found mainly in
Triton X-100 soluble cytoplasm fractions, and increased after 24 h
of TNFa stimulation. In contrast, ZO-1 and Occludin (epithelial
surface markers) were mainly found in Triton X-100 insoluble
precipitates. GAPDH, a cytosolic protein was found mainly in
Triton X-100 soluble fraction (Figure 3C). Therefore, our results
suggest that the increased Claudin 1 is not mainly in tight junction
but diffusely distributed in the cytoplasm.
Table 1. Top 20 up-regulated genes induced by TNFa in Control-siRNA or Claudin 1-siRNA transfected A549 cells.
Up-Regulated Genes
Gene Symbol Gene Name Gene ID Control-siRNA Claudin 1-siRNA
Fold Change q-value (%) Fold Change q-value (%)
CCL5 chemokine (C-C motif) ligand 5 NM_002985 21.729 ,0.001 11.471 ,0.001
CLEC4E C-type lectin domain family 4, member E NM_014358 14.712 ,0.001 6.523 ,0.001
IL8 interleukin 8 NM_000584 9.634 ,0.001 3.136 ,0.001
IL6 interleukin 6 (interferon, beta 2) NM_000600 8.530 ,0.001 5.958 ,0.001
TNFAIP3 tumor necrosis factor, alpha-induced protein 3 NM_006290 8.188 ,0.001 3.764 ,0.001
CCL2 chemokine (C-C motif) ligand 2 NM_002982 4.466 ,0.001 2.387 ,0.001
SOD2 superoxide dismutase 2, mitochondrial NM_001024465 4.404 ,0.001 2.617 ,0.001
IL1A interleukin 1, alpha NM_000575 4.258 ,0.001 4.128 ,0.001
CFB complement factor B NM_001710 4.202 ,0.001 2.020 ,0.001
IFI44 interferon-induced protein 44 NM_006417 3.833 ,0.001 2.448 3.500
EFNA1 ephrin-A1 NM_004428 3.819 ,0.001 1.718 $5.0
PTX3 pentraxin-related gene, rapidly induced by IL-1 beta NM_002852 3.762 ,0.001 1.982 4.154
ASS1 argininosuccinate synthetase 1 NM_000050 3.589 ,0.001 2.003 ,0.001
PTPLAD2 protein tyrosine phosphatase-like A domain containing 2 NM_001010915 3.432 ,0.001 1.988 ,0.001
VCAM1 vascular cell adhesion molecule 1 NM_001078 3.418 ,0.001 1.961 4.221
GPR141 G protein-coupled receptor 141 NM_181791 3.343 ,0.001 2.805 ,0.001
C15orf48 chromosome 15 open reading frame 48 NM_032413 3.239 ,0.001 2.476 ,0.001
LAMC2 laminin, gamma 2 NM_005562 3.082 ,0.001 2.696 ,0.001
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 NM_001548 3.002 ,0.001 2.240 $5.0
TNFRSF9 tumor necrosis factor receptor superfamily, member 9 NM_001561 2.984 ,0.001 2.721 ,0.001
doi:10.1371/journal.pone.0038049.t001
Table 2. Top 10 down-regulated genes induced by TNFa in Control-siRNA or Claudin 1-siRNA transfected A549 cells.
Down-Regulated Genes
Gene
Symbol Gene Name Gene ID Control-siRNA Claudin 1-siRNA
Fold Change q-value (%) Fold Changeq-value (%)
BAAT bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-
choloyltransferase)
NM_001701 23.632 ,0.001 22.580 $5.0
TM4SF4 transmembrane 4 L six family member 4 NM_004617 22.289 0.387 21.943 $5.0
HLA-DMB major histocompatibility complex, class II, DM beta NM_002118 21.963 2.306 21.985 $5.0
OLFML3 olfactomedin-like 3 NM_020190 21.865 3.152 21.623 $5.0
C12orf27 chromosome 12 open reading frame 27 ENST00000315185 21.822 3.186 21.579 $5.0
METTL7A methyltransferase like 7A NM_014033 21.733 3.818 21.324 $5.0
C5 complement component 5 NM_001735 21.644 3.818 21.521 $5.0
ACSM3 acyl-CoA synthetase medium-chain family member 3 NM_005622 21.630 3.152 21.651 $5.0
TRIML2 tripartite motif family-like 2 NM_173553 21.626 3.152 21.440 $5.0
SEMA3E sema domain, immunoglobulin domain (Ig), short basic domain NM_012431 21.609 3.152 21.262 $5.0
doi:10.1371/journal.pone.0038049.t002
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blocked TNFa-induced gene expression
To determine the role of Claudin 1 in TNFa related cellular
functions, we used microarray to analyze gene expression profiles
in cells treated with or without TNFa and in the presence of
Claudin 1 siRNA or control siRNA. TNFa stimulation (20 ng/ml
for 24 h) increased Claudin 1 mRNA expression, while Claudin 1
siRNA effectively reduced both basal level and TNFa-induced
Claudin 1 gene expression (Figure 4A). Interestingly, TNFa
reduced Claudin 2 gene expression, which was not affected by
Claudin 1 siRNA treatment. TNFa has no significant effects on
other Claudin family members (Table S1). Principle Component
Analysis (PCA) indicated that the overall gene expression patterns
were clearly separated based on either the TNFa stimulation or
Claudin 1 siRNA pre-treatments (Figure 4B). Hierarchical cluster
analysis showed that the down regulation of Claudin 1 with siRNA
has a profound effect on the gene expression profile. A group of
genes were up-regulated in Claudin 1 siRNA treated cells, and
another group of genes were down-regulated, regardless of TNFa
treatment (Figure 4C).
As expected, TNFa stimulation altered expression of many
genes. One group of genes was up-regulated by TNFa in both
Control and Claudin 1 siRNA transfected cells (Figure 4C, red
arrow). However, another group of genes regulated by TNFa in
Control siRNA transfected cells are less regulated in Claudin 1
siRNA transfected cells (Figure 4C, blue arrow). Significance
Analysis of Microarray (SAM) was performed to detect genes
significantly changed by TNFa treatment, which is indicated by
False Discovery Rate (FDR) q value less than 5.0% and fold
change greater than 1.3. In control siRNA transfected cells, TNFa
changed expression of 468 genes, of which 450 genes were up-
regulated, whereas only 18 genes were down-regulated. In
contrast, in Claudin 1 siRNA transfected cells, only 123 genes
were significantly changed by TNFa, and all of them were up-
regulated. The Venn diagram revealed that 353 of the genes
altered by TNFa in Control siRNA transfected cells are not
changed in Claudin 1 siRNA transfected cells. This means that
knock-down of Claudin 1 blocked 75% of the TNFa-induced gene
expression changes (Figure 4D). The top 20 genes up-regulated by
TNFa are listed in Table 1. The folds of changes were decreased
in Claudin 1 siRNA treated group in most of these genes. The top
20 down-regulated genes by TNFa are listed in Table 2. None of
them remains significantly changed in Claudin 1 siRNA treated
group. Six genes from up- or down-regulated genes were verified
with qRT-PCR. Similar trends between microarray and qRT-
PCR were observed (Figure 5). These results indicate that Claudin
1 plays an important role in mediating TNFa-induced gene
expression.
Claudin 1 siRNA blocked TNFa-induced genes are related
to cell migration
We further analyzed Bio-functions of the 353 genes, which were
blocked by Claudin 1 siRNA (highlighted area with dots on Venn
diagram in Figure 4D). Among these significantly changed genes,
Figure 6. Knocking down Claudin 1 with siRNA reduced gene expression related to inflammation and cell migration. Ingenuity
Pathway Analysis was performed on 353 genes which were significantly changed by TNFa treatment in Control siRNA transfected cells, but not in
Claudin 1 siRNA transfected cells (highlighted area with dots on Venn diagram in Fig. 4D). (A) Signal network related to inflammation. Note that NFkB
is located at the center of the network. (B) Signal network related to cell movement. Note MMP-9 is located at the center of the network.
doi:10.1371/journal.pone.0038049.g006
Table 3. Top Bio Functions of TNFa-Induced Genes Blocked
by Claudin 1 siRNA, as analyzed by Ingenuity Pathway
analysis.
Top Bio Functions
Molecular and Cellular Functions
Name p-value Number of Molecules
Antigen Presentation 8.33E-12–6.75E-03 74
Cellular Development 6.06E-09–6.75E-03 62
Gene Expression 2.94E-07–7.93E-03 21
Cellular Movement 2.16E-06–7.36E-03 53
Cell Death 2.90E-06–7.41E-03 86
doi:10.1371/journal.pone.0038049.t003
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Cellular Movement, Cell-To-Cell Signaling and Interaction,
Tumor Morphology and/or Cell Morphology (Table S2).
Ingenuity Pathway Analysis shows that the top ranked functional
networks blocked by Claudin 1 siRNA treatment are related to
antigen presentation, cellular development, gene expression,
cellular movement and cell death (Table 3). In two of these
functional networks, NFkB is well connected as a central hub of
multiple molecules. One of them is related to antigen presentation
(data now shown) and another is related to inflammation
(Figure 6A, Table S3A). Recent studies have demonstrated that
NFkB promotes EMT, migration and invasion in cancer cells
[14,43,44]. In the functional network on Cellular Movement,
MMP-9 is located in the center (Figure 6B, Table S3B). MMP-9 is
one of the most important proteases for human lung epithelial cell
migration [27,45].
Claudin 1 is important for TNFa-induced cell migration in
A549 cells
To determine whether Claudin 1 is involved in TNFa-induced
cell migration, we first compared the role of TNFa and TGFb1i n
cell migration with a wound-healing assay. TNFa plus TGFb1
treatment significantly increased motility in A549 cells (Figure 7A
and 7B). TNFa alone, but not TGFb1, increased wound closure as
effectively as TNFa plus TGFb1 did (Figure 7B). To determine the
increased wound closure is due to increase cell proliferation and/
or migration, we examined the effects of TNFa and/or TGFb on
cell proliferation with MTS assay. Neither or both of them affected
cell proliferation within 24 h of treatment (Figure 7C). Microarray
and qRT-PCR demonstrated that TNFa increased MMP-9 gene
expression. A gelatin zymography assay demonstrated that the
level of active-MMP 9 was increased by TNFa treatment; while
the levels of both pro- and active-MMP 2 had no dramatic
changes (Figure 7D). These results indicate that TNFa is
responsible for increased cell migration.
Figure 7. TNFa promotes migration of A549 cells. (A) TNFa enhanced cell migration in a wound healing assay. After mechanical wounding,
confluent A549 cells were treated with TNFa (20 ng/ml), TGFb1 (10 ng/ml) or TNFa and TGFb1 together. Representative photomicrographs of the
wounded cell monolayer are shown. (B) Percentage of cell free area in each condition was calculated. n=4. Mean 6 SEM. *p,0.05 (compared with
control at the same time point). (C) TNFa and/or TGFb1 did not affect cell proliferation determined by MTS assay. (D) TNFa treatment for 24 h
increased the gene expression of MMP-9 (as determined by microarray and qRT-PCR) and the level of active MMP-9, while the levels of both pro- and
active-MMP 2 had no dramatic changes, as determined by gelatin zymography assay.
doi:10.1371/journal.pone.0038049.g007
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both the basal and TNFa-induced expression of Claudin 1 mRNA
(Table S1) and protein (Figure 8C) levels and cell migration
(Figure 8A and 8B). Next, we transfected A549 cells with Claudin
1-pcDNA, which effectively enhanced cell migration (Figure 8D
and 8E). Western blotting confirmed that Claudin 1-pcDNA
transfection increased the expression level of Claudin 1 protein
(Figure 8F). Collectively, these results indicate that Claudin 1 has
important role in mediating TNFa-induced cell migration.
To determine whether the role of Claudin 1 in TNFa-induced
cell migration is specific, cells were serum-starved for 3 h and then
stimulated with 10% serum and/or EGF (50 ng/ml). Serum plus
EGF significantly increased cell migration. Interestingly, Claudin 1
siRNA transfected cells showed significantly increased migration
in either EGF or serum treated group. This is more significant in
cells treated with both serum and EGF (Figure 9A). We then
performed western blotting, serum and/or EGF slightly increased
Claudin 1 protein levels. Claudin 1 siRNA effectively reduced the
levels of Claudin 1 (Figure 9B). To test whether down-regulation of
Claudin 1 can alter TNFa-induced cell morphology changes, cells
were treated with control or Claudin 1 siRNA and stimulated with
TNFa, and/or TGFb.Claudin 1 siRNA reduced the morpholog-
ical changes induced by TNFa alone or by TNFa plus TGFb, and
TGFb alone had little effects on stress fiber formation and cell
morphology, as shown by F-actin staining (Figure 9C).
Discussion
One of the novel findings of the present study is the evidence
that in human lung cancer A549 cells TNFa alone induced
morphological changes, stress fiber formation, cell migration and
the alteration of gene expression. More importantly, we found that
these cellular functions are largely mediated through the induction
of Claudin 1.
TNFa is known to augment TGFb1-induced EMT in various
cells [12,13,46,47]. To investigate EMT in A549 cells, we treated
cells with TNFa, TGFb1 or in combination, and examined the
morphological changes, cytoskeletal structure and expression of
EMT markers. Through these experiments, we found that TNFa
and TGFb1 may have different roles in these human lung cancer
cells. TGFb1 is more effectively inhibiting expression of E-
Cadherin, a marker for the differentiation of epithelial cells,
whereas TNFa is more effective in increasing Claudin 1 expression
and through Claudin 1 to mediate down-stream gene expression
Figure 8. Claudin 1 expression levels affect cell migration. (A) Down regulation of Claudin 1 with siRNA reduced spontaneous as well as TNFa-
enhanced migration of A549 cells. The control or Claudin 1 siRNA transfected A549 cells were cultured until confluent, mechanically wounded, and
then treated with or without 20 ng/ml TNFa. Representative photomicrographs of wounded cell monolayer are shown. (B) Percentage of cell free
area in each condition was calculated. n=4. Mean 6 SEM. *p,0.05 (compared with control siRNA transfected cells at the same time point). (C)
Claudin 1 siRNA effectively reduced both basal and TNFa induced expression levels of Claudin 1 in A549 cells. Control or Claudin 1 siRNA transfected
cells were treated with or without TNFa (20 ng/ml for 24 h) and harvested for western blotting. (D) Over-expression of Claudin 1 enhanced cell
migration. (E) Percentage of cell free area in each condition was calculated. n=4. Mean 6 SEM. *p,0.05, compared with empty vector transfected
cells at the same time point. (F) Claudin 1-pcDNA effectively increased the expression level of Claudin 1. A549 cells were transfected with empty
vector or Claudin 1-pcDNA for 24 h, and harvested for western blotting.
doi:10.1371/journal.pone.0038049.g008
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of human colonic organoids [11], promoted EMT in renal
carcinoma cells [48,49] and in human skin cells [50]. In A549
cells, TNFa alone induced cell morphological changes and cell
migration. Although these changes are related to EMT, we do not
have enough evidence to support TNFa alone induced EMT in
this cell type.
Normally, Claudin 1 expresses in lung epithelial cells and
regulates tight junction permeability [51]. Claudin 1 expression is
generally known to be decreased by TNFa, and the decreased
protein expression and protein redistribution of Claudin 1 lead to
the decrease in the trans-epithelial electric resistance and the
increase in the paracellular permeability of epithelial cells [52,53].
TNFa increased Claudin 1 expression in human pancreatic cancer
cells [54], and in airway smooth muscle cells [55]. In the present
study, TNFa strongly increased Claudin 1 expression in human
lung cancer cells. The increased Claudin 1 is mainly in Triton-
soluble cytoplasm, not in the tight junction complex of Triton-
insoluble fraction. More importantly, knock-down of Claudin 1
blocked 75% of the TNFa-induced gene expression changes. Two
of the top five TNFa-induced functional networks effectively
blocked by Claudin 1 siRNA are related to NFkB. It has been
shown that NFkB signaling is involved in EMT [14,43,44]. In the
Table 1, we can see several cytokines and chemokines on the top
of the gene list up-regulated by TNFa, such as CCL5, CCL2, IL-
8, IL-6 and IL-1a. The folds of changes of these genes were
significantly lower in Claudin 1 siRNA treated cells. In the NFkB
related inflammatory signal network (Figure 6A, Table S3A), genes
encoding proteins related to inflammation can be identified, such
as CXCL10 (chemokine CXC motif ligand 10), CSF2 (colony
stimulating factor 2), PLA2G4A and PLA2G4C (phospholipase
A2, group IV members), KLRK1 and KLRC3 (killer cell lectin-
like receptor subfamily members), and S100A3 (S100 calcium
binding protein A3). TNFa is one of the most important
inflammatory mediators in tumorigenesis. Our results suggest that
Claudin 1 may be a crucial mediator in TNFa-initiated
inflammatory responses.
In the signal network related to cell migration, genes are
centered on MMP-9 (Figure 6B, Table S3B). Indeed, the gene
expression, protein level and activity of MMP-9 were increased
after TNFa stimulation. PLAT, PLAU and PLAUR (stands for
plasminogen activator, tissue type, urokinase type and PLAU
receptor, respectively) are among the genes blocked by Claudin 1
siRNA. They are important players in the cell migration. Collagen
type IV alpha-1 (COL4A1) and nidogen-2 (NID2) are components
of the basement membrane, and may play a role in cell
interactions with extracellular matrix. Furthermore, over 100
genes listed in Table S2 are related to cellular movements, cell-to-
cell interaction, tumor morphology and cell morphology. These
data indicate the importance of Claudin 1 in mediating TNFa
related lung cancer cell migration. The increased expression of
Claudin-1 in colon cancer cells resulted in increased tumor growth
Figure 9. Reducing Claudin 1 protein levels enhanced serum and/or EGF induced A549 cell migration, and Claudin 1 siRNA reduced
TNFa-induced morphological changes of A549 cells. Cells were transfected with Claudin 1 or control siRNA. The confluence monolayers were
serum starved, mechanically wounded and then stimulated with serum (10% FBS) and/or EGF (50 ng/ml). The wounded areas at 12 h were
quantified. N=4, Mean 6 SEM. *P,0.05 vs. control siRNA treated group. (B). Claudin 1 siRNA clearly reduced Claudin 1 protein levels as shown by
Western blotting. (C). Claudin 1 siRNA reduced TNFa- and TNFa plus TGFb-induced morphological changes as shown by F-actin staining at 48 h.
Similar results were also found after 24 h or 72 h of TNFa treatment.
doi:10.1371/journal.pone.0038049.g009
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1 in metastatic colon cancer cells inhibited migration and invasion
[23]. Similarly, Claudin 1 over-expression increased cell motility in
oral squamous cell carcinoma, melanoma and hepatocellular
carcinoma [24–26].
In contrast to these findings, in human lung cancer CL1–5 cells,
over expression of Claudin 1 inhibited cell migration, whereas
knockdown of Claudin 1 restored the migration and invasive
ability of cells with stably transfection of Claudin 1 [56]. In the
present study, Claudin 1 siRNA transfection enhanced cell
migration stimulated by EGF and/or serum in A549 cells
(Figure 9). As a TJ protein Claudin 1 participates in the cell-to-
cell adhesion. Its down-regulation may reduce the TJs and thus,
promote cell migration. TNFa-induced Claudin 1, on other hand
is mainly in the cytoplasm, and is involved in TNFa-induced gene
expression. Since many of these Claudin 1 dependent genes are
related to cell movement and morphology, Claudin 1 may mediate
TNFa-initiated cell migration with multiple mechanisms.
In summary, we found that TNFa stimulation induces the gene
expression of Claudin 1 in human lung cancer cells, and the latter
acts as the signal mediator to regulate gene expression and cell
migration. Further study on this pathway may serve as a mean to
develop a novel therapeutic target for cancer.
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